Inside informationEnglish
Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Valneva SE
- Filed
- 26/11/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 110949_20251126